See Cancer Control Journal of the Moffitt Cancer Center. Vol. 12,
September 2005., Supplement 1 "Venous Thromboembolism and
Cancer:Current Issues and Treatment Directions"
www.MoffittCancerCenter.org/ccjournal
page 34 question #7.
-----Original Message-----
From: [EMAIL PROTECTED]
To: [EMAIL PROTECTED]; [EMAIL PROTECTED]
Sent: Wed, 13 Sep 2006 9:30 AM
Subject: Re: FW: Portacath warfarin prophylaxis
This is a controversial issue. There are small studies in oncology
patients that support its use and some that do not. There was a series
of practice guidelines related to anticoagulants and thrombolytics
published in Chest 2004 and they recommended against its use. My
opinion of that piece was that they did not have a good understanding
of the true clinical impact of catheter-related thrombosis. But that is
the most recent thing I can recommend. Lynn
At 8:24 AM -0700 9/13/06, Marilyn Patterson wrote:
This question from an internal medicine doc. Has this recommendation
changed? Does any one have any references I can forward to this MD?
Thanks as always so much for all your valued input and expertise.
Marilyn Patterson RN CRN, CRNI Port Angeles, WA --------
From: Mark Fischer
Sent: Tuesday, September 12, 2006 3:41 PM
To: Marilyn Patterson; Tami Spaeder
Subject: Portacath warfarin prophylaxis Hi Marilyn or Tami
Historically, pt's have taken warfarin 1mg/day for this.. Recently, I
think I've heard this is no longer recommended, right ? Do you have a
reference to support this ? Thanks mark
--
Lynn Hadaway, M.Ed., RNC, CRNI
Lynn Hadaway Associates, Inc.
126 Main Street, PO Box 10
Milner, GA 30257
http://www.hadawayassociates.com
office 770-358-7861
________________________________________________________________________
Check out the new AOL. Most comprehensive set of free safety and
security tools, free access to millions of high-quality videos from
across the web, free AOL Mail and more.
